Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option
Authors
Keywords
-
Journal
EYE
Volume 31, Issue 11, Pages 1523-1536
Publisher
Springer Nature
Online
2017-05-26
DOI
10.1038/eye.2017.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration
- (2016) Maiko Inoue et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Response of Pigment Epithelial Detachment to Anti–Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration
- (2016) Han Joo Cho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration
- (2016) Ahmad M Mansour et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration
- (2016) Cheolmin Yun et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study
- (2016) Jae Hui Kim et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- One-year outcomes of a treat-and-extend regimen of intravitreal aflibercept for polypoidal choroidal vasculopathy
- (2016) Mio Hosokawa et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration
- (2016) Wataru Kikushima et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Aflibercept as First-Line Therapy in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Prospective Case Series Analysis in Real-Life Clinical Practice
- (2016) Patricia Udaondo et al. OPHTHALMOLOGICA
- Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid
- (2016) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials
- (2016) Sebastian M. Waldstein et al. OPHTHALMOLOGY
- First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
- (2016) James S. Talks et al. OPHTHALMOLOGY
- SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT
- (2016) Jay Chhablani et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION
- (2016) Hidetaka Matsumoto et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials
- (2016) Darius M. Moshfeghi et al. Ophthalmic Surgery Lasers & Imaging Retina
- Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration
- (2015) Ali Dirani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- One-Year Result of Aflibercept Treatment on Age-Related Macular Degeneration and Predictive Factors for Visual Outcome
- (2015) Akio Oishi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ziv-aflibercept in macular disease
- (2015) Ahmad M Mansour et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
- (2015) Xiaochuan Huo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing
- (2015) Shelagh M. Szabo et al. CURRENT MEDICAL RESEARCH AND OPINION
- Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
- (2015) M McKibbin et al. EYE
- Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion
- (2015) Jay Chhablani INDIAN JOURNAL OF OPHTHALMOLOGY
- Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration
- (2015) Martin Sebastian Zinkernagel et al. OPHTHALMOLOGICA
- Scheduled versus Pro Re Nata Dosing in the VIEW Trials
- (2015) Gisbert Richard et al. OPHTHALMOLOGY
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- Pigment Epithelial Detachment Followed by Retinal Cystoid Degeneration Leads to Vision Loss in Treatment of Neovascular Age-Related Macular Degeneration
- (2015) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture
- (2014) Deepika Malik et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
- (2014) Michael W Stewart Expert Review of Clinical Pharmacology
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Clinical Application of Therapies Targeting VEGF
- (2010) George D. Yancopoulos CELL
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now